Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01418261 · ClinicalTrials.gov registry record · NA
SYMPLICITY HTN-3 Renal Denervation in Patients With Uncontrolled Hypertension
A NA study, sponsored by Medtronic Vascular.
- Completed
- Registry status
- NA
- Development phase
- 535
- Enrollment target
NCT01418261 is a NA study that has completed, run by Medtronic Vascular. The registered enrollment target is 535 participants.
The verdict
NCT01418261, a NA study, has completed, sponsored by Medtronic Vascular.
- COMPLETED
- Registry status
- NA
- Development phase
- 535 participants
- Enrollment target
Study Summary
The Symplicity HTN-3 study is a, multi-center, prospective, single-blind, randomized, controlled study of the safety and effectiveness of renal denervation in subjects with uncontrolled hypertension. Bilateral renal denervation will be performed using the Symplicity Catheter - a percutaneous system that delivers radiofrequency (RF)energy through the luminal surface of the renal artery.
Interventions
- DEVICE Renal denervation (Symplicity Catheter System)
- DIAGNOSTIC_TEST Renal angiogram
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 535 participants |
| Start Date | 2011-09 |
| Est. Completion | 2017-02-17 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01418261
The ClinicalTrials.gov registry entry for NCT01418261 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 535 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Medtronic Vascular, which has 26 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Renal denervation (Symplicity Catheter System) is the first listed.
NCT01418261 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01418261 about?
NCT01418261 is a clinical study titled "SYMPLICITY HTN-3 Renal Denervation in Patients With Uncontrolled Hypertension". The Symplicity HTN-3 study is a, multi-center, prospective, single-blind, randomized, controlled study of the safety and effectiveness of renal denervation in subjects with uncontrolled hypertension. Bilateral renal denervation will be performed using the Symplicity Catheter - a percutaneous system ...
What is the current status of trial NCT01418261?
This trial is currently completed. It is a NA study. The enrollment target is 535 participants. The study started on 2011-09. Estimated completion is 2017-02-17.
What interventions are being tested in trial NCT01418261?
The interventions under investigation include: Renal denervation (Symplicity Catheter System) (DEVICE), Renal angiogram (DIAGNOSTIC_TEST).
Who is sponsoring clinical trial NCT01418261?
This trial is sponsored by Medtronic Vascular, which has 26 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.